To evaluate the cytotoxic effect of TOPK inhibitor in combination with cisplatin in non-small cell lung cancer
碩士 === 輔仁大學 === 生命科學系碩士班 === 103 === Surgical resection and cisplatin-based chemotherapy are the mainstays of treatment for EGFR wild type lung cancer patients. However, cisplatin has many side effects and has been reported to select the generation of CSCs (cancer stem cells), thereby causing drug r...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2015
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/53462596390468237179 |